Amedisys CEO Bill Borne thinks his company can be part of the solution for controlling the costs of Medicare, the federal health care program for the elderly. Meanwhile, the company’s billing practices, along with those of other publicly traded home health care companies, including Lafayette-based LHC Group, are under investigation by the federal government. But Borne says his industry continues to make its case for a greater role in the nation’s health care system. “We meet with [the Centers for Medicare & Medicaid Services] monthly now,” he says. “We meet with MedPac [the Congressional Medicare Payment Advisory Commission] probably twice a year. While there’s still a lot of skepticism, they see that the industry is starting to address their concerns.” The investigations began last year after a Wall Street Journal report questioned if Baton Rouge-based Amedisys and other companies were taking undue advantage of a Medicare reimbursement program. Amedisys has denied that it changed the number of therapy visits to get a higher reimbursement and said it will comply with the investigation. Borne says the probe into billing practices could go on for years. “It’s not unusual for a company our size in Medicare to have these sorts of inquiries,” he says. “They go on all the time.” —David Jacobs
Amedisys head says discussions with feds go on despite investigations
Sign up for the free Daily Report email – local news about the people, companies and issues that impact business impact business in Baton Rouge and beyond.
